Latest filing published 03 Sept 2026 for Apogee Therapeutics, Inc., €203.9M.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Nimish P. Shah: trading record in brief
Nimish P. Shah is a declared insider at 2 companies; the most frequent names are Instil Bio, Inc. and Apogee Therapeutics, Inc. In total, 12 filings cover trades dated from 23 March 2021 to 3 September 2026.
On the market, this insider has only ever bought: 6 purchases, €31.5M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €1.3M. Of 6 purchases, 6 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
On 3 September 2026 came the latest disclosure, a transaction for €203.9M in Apogee Therapeutics, Inc. The last purchase on record was published on 17 July 2023, which is 1,210 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nimish P. Shah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,750,000 shares@ US$135.11Common StockSEC:0001140361-26-035608:0
- 1,750,000 shares@ US$17.00100.0% of flowCommon StockSEC:0001104659-23-081730:0Canonical exit: 11 Oct 2023 (T+90)
2 of 2 declarations
